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Together with its presynaptic partner Neurexin 1 (Nxn1), Neuroligin 1 (NL1) participates
in synapse specification and synapse maintenance. We and others have shown that
NL1 can also modulate glutamatergic synaptic function in the central nervous system
of rodent models. These molecular/cellular changes can translate into altered animal
behaviors that are thought to be analogous to symptomatology of neuropsychiatric
disorders. For example, in dorsal striatum of NL1 deletion mice, we previously
reported that the ratio N-methyl-D-aspartate receptor (NMDAR) mediated synaptic
currents to α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor (AMPAR)
mediated synaptic currents (NMDA/AMPA) is reduced in medium spiny neuron (MSNs).
Importantly, this reduction in NMDA/AMPA ratio correlated with increased repetitive
grooming. The striatum is the input nucleus of the basal ganglia (BG). Classical models
of this circuitry imply that there are two principal pathways that render distinct and
somewhat opposite striatal outputs critical to the function of these nuclei in modulating
motor behavior. Thus, we set out to better characterize the effects of NL1 deletion
on direct and indirect pathways of the dorsal striatum by genetically labeling MSNs
participating in the direct and indirect pathways. We demonstrate that a decrease in
NMDAR-mediated currents is limited to MSNs of the direct pathway. Furthermore,
the decrease in NMDAR-mediated currents is largely due to a reduction in function
of NMDARs containing the GluN2A subunit. In contrast, indirect pathway MSNs in
NL1 knockout (KO) mice showed a reduction in the frequency of miniature excitatory
neurotransmission not observed in the direct pathway. Thus, NL1 deletion differentially
affects direct and indirect pathway MSNs in dorsal striatum. These findings have
potential implications for striatal function in NL1 KO mice.
Keywords: Neuroligin 1, GluN2A, GluN2B, mEPSC, synaptic transmission, autism spectrum disorders, medium
spiny neuron (MSN), NMDA
Introduction
Alterations in the postsynaptic cell-adhesion molecule Neuroligin-1 (NL1) and its trans-
synaptic partner Neurexin-1 (Nxn1) are associated with neuropsychiatric disorders
such as autism spectrum disorders (ASD; Szatmari et al., 2007; Kim et al., 2008a;
Kirov et al., 2008, 2009; Marshall et al., 2008; Walsh et al., 2008; Yan et al., 2008;
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Zahir et al., 2008; Glessner et al., 2009; Gratacòs et al., 2009;
Millson et al., 2012; An et al., 2014), and may also be involved
in cognitive decline in the Alzheimer’s disease (Saura et al., 2011;
Bie et al., 2014). These cell-adhesion molecules are critical for
synapse specification and function via interactions with partners
that constitute the neurotransmission machinery on both sides
of the synapse (Scheiffele et al., 2000; Missler et al., 2003; Graf
et al., 2004; Prange et al., 2004; Sara et al., 2005; Gerrow et al.,
2006; Chubykin et al., 2007; Mukherjee et al., 2008). NL1 is
specific to excitatory synapses where it promotes the retention of
α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors
(AMPARs; Heine et al., 2008; Mondin et al., 2011) as well as
the clustering of N-methyl-D-aspartate receptors (NMDARs) by
indirect intracellular (Barrow et al., 2009) and direct extracellular
interactions (Budreck et al., 2013) both early during spinogenesis
and in mature synapses. Many research laboratories have
identified physiological alterations in several brain regions in
neuroligin models (Levinson et al., 2005; Nam and Chen, 2005;
Varoqueaux et al., 2006; Chubykin et al., 2007; Futai et al., 2007;
Kim et al., 2008b; Wittenmayer et al., 2009; Blundell et al., 2010;
Dahlhaus et al., 2010; Jung et al., 2010; Ko et al., 2011; Mondin
et al., 2011; Shipman et al., 2011; Soler-Llavina et al., 2011;
Burton et al., 2012; Kwon et al., 2012; Schnell et al., 2012, 2014;
Shipman and Nicoll, 2012; Hoy et al., 2013; Bie et al., 2014).
Among them, the reduction in NMDA/AMPA ratio and synaptic
plasticity had been repeatedly demonstrated as a result of NL1
deletion (Kim et al., 2008b; Ko et al., 2009b; Blundell et al.,
2010; Dahlhaus et al., 2010; Jung et al., 2010; Shipman et al.,
2011; Soler-Llavina et al., 2011; Kwon et al., 2012; Shipman and
Nicoll, 2012; Hoy et al., 2013; Bie et al., 2014). Also, even though
NL1 is a postsynaptic protein, altering its expression levels also
has presynaptic consequences including effects on clustering
of synaptic vesicles (Wittenmayer et al., 2009; Dahlhaus et al.,
2010) and on the frequency of spontaneous miniature excitatory
postsynaptic currents (mEPSCs; Prange et al., 2004; Nam and
Chen, 2005; Chen et al., 2010; Mondin et al., 2011; Burton et al.,
2012; Kwon et al., 2012; Schnell et al., 2012).
The basal ganglia (BG) are an essential component of larger
parallel circuits implicated in modulation of lower-order motor
control and higher-order habit formation (Villablanca and
Marcus, 1975; Yin and Knowlton, 2006; Graybiel, 2008). BG
circuitry is segregated in two main pathways with differential
gene expression (Gerfen et al., 1990; Lobo et al., 2006) and,
most importantly, with outputs of more or less opposite effects
on motor and cognitive ‘‘programs’’ (Villablanca and Marcus,
1975; Yin and Knowlton, 2006; Graybiel, 2008). The output
projections from the striatum are originated in medium spiny
neurons (MSNs) of either the striatonigral (direct) pathway or
the striatopallidal (indirect) pathway. Imbalances in the output
of these pathways are thought to be critical in the generation of
repetitive/perseverative-like behaviors in animals and humans.
Striatal synaptic alterations that correlate with repetitive
behaviors have been shown in several genetic animal models
(Greer and Capecchi, 2002; Welch et al., 2007; Blundell et al.,
2010; Shmelkov et al., 2010; Chen et al., 2011; Peça et al., 2011;
Wan et al., 2011, 2014) and could be involved in analogous
symptomatology present in humans (Nicolini et al., 1996;
Abelson et al., 2005; Miguel et al., 2005; Bienvenu et al., 2009). In
accord, we recently demonstrated that reduced NMDA/AMPA
ratio in glutamatergic projections onto striatal MSNs correlated
with increased grooming in NL1 knockout (KO) mice (Blundell
et al., 2010), a phenotype reversed by D-cycloserine (a NMDAR
co-agonist), suggesting a relationship between a reduction in
NMDAR currents and grooming.
In an effort to better define synaptic dysfunction in striatal
circuits in the setting of NL1 deletion, we crossed genetic markers
of direct and indirect pathway MSNs into our NL1 KO mice.
These markers allow us to examine pathway-specific effects
of NL1 deletion on dorsal striatum circuitry. Interestingly, we
have demonstrated pathway-specific alterations in glutamatergic
inputs onto direct and indirect pathway MSNs. Specifically,
alterations in NMDAR-mediated currents are limited to the
direct pathway while different synaptic abnormalities were
demonstrated in the indirect pathway. We further refine
the mechanism of reduced NMDAR function by implicating
GluN2A-containing receptors. Here we replicate our previous
work (Blundell et al., 2010) and extend those findings to show
pathway-specific and subunit-specific alterations in NMDAR
currents as well as other aspects of striatal synaptic function.
Materials and Methods
Mice
All experiments were performed in accord with the University
of Texas Southwestern Medical Center Animal Care and Use
Committee in compliance with National Institutes of Health
guidelines for the care and use of experimental animals. The NL1
KO mouse was generated as described previously (Varoqueaux
et al., 2006). The background of our original NL1 mutant line
is a hybrid 129S6/SvEVTac X C57BL/6J cross. These mice were
crossed once to mice expressing distinct fluorescent markers in
the direct pathway (NL1/DR1 mice, td-Tomato driven by the
dopamine-1 receptor promoter; Shuen et al., 2008) and in the
indirect pathway (NL1/DR2 mice, enhanced green fluorescent
protein driven by the dopamine-2 receptor promoter; Gong et al.,
2003). In an effort to preserve the original hybrid background,
we then backcrossed each of these ‘‘labeled’’ mice for five
generations into the original hybrid NL1 mutant background.
In order to obtain mice in which both D1 and D2 MSNs
were labeled, we crossed heterozygous NL1 mice with the
fluorescent markers to one another for three generations. NL1
heterozygous F3 mice expressing markers in both pathways were
then used as breeders to generate WT and NL1 KO individuals
for experiments as well as NL1 heterozygous mice to replace
breeders. These crosses created the added benefit of uniform
genetic background across all experiments.
Recently the use of bacterial artificial chromosome (BAC)
transgenic mice expressing EGFP driven by the DR2 promoter
had been called into question because, when comparing to wild-
type (WT) mice, an increased expression of the D2 receptor
as well as a mild hyperactive phenotype were found in these
mice but not in BAC transgenic mice expressing either EGFP
or td-Tomato in the direct pathway (Ade et al., 2011; Kramer
et al., 2011). Later reports from several groups suggest that
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strain-specific, high-sensitivity may have been the culprit for
those findings (Chan et al., 2012; Nelson et al., 2012). In the
present study, comparisons are made between WT and NL1 KO
mice that both express either D1 or D2 labeled BAC transgenes.
Thus, any effects of these transgenes are equivalent in both WT
and NL1 KO groups. Furthermore, our use of hybrid genetic
backgrounds may obviate this potential confound (Gertler et al.,
2008; Grueter et al., 2010; Lobo et al., 2010; Chan et al., 2012;
Nelson et al., 2012).
Genotyping
Genotyping was performed by PCR of genomic DNA extracted
from tails. For NL1 genotyping the following primers were used:
MB0606 (WT-specific), 5′-CGA GAG TCA GGT AAA TTG
AAC ACC AC-3′; T676 (KO-specific), 5′-GAG CGC GCG CGG
CGG AGT TGT TGA C-3′; and T1660 (common), 5′-GTG
AGC TGA ATC TTA TGG TTA GAT GGG-3′. Importantly,
given that amplification of the mutant PCR fragment was
significantly more efficient than the amplification of the WT
PCR fragment, we used a 3:1–4:1 ratio of WT-specific primer
vs. the KO-specific primer. PCR products were run in a
1.6–1.8% agarose gel. WT and KO PCR product sizes were:
∼550 bp and ∼415 bp, respectively. The PCR protocol was:
1 step at 98◦C for 3 min; 30 cycles of 98◦C for 15 s, 65◦C
for 30 s and 72◦C for 20 s; a final step at 72◦C for 5 min.
Genotyping for DR1-tdTomato transgene or for DR2-EGFP
transgene, was done using same procedures as in Ade et al.
(2011).
Striatal Neurotransmission
Horizontal-oblique slices were prepared from NL1/D1 and
D2 mouse brains, and acute slice striatal recordings were
performed as previously described (Ding et al., 2008; Smeal
et al., 2008; Blundell et al., 2010). Briefly, 2–3 week old
WT and KO mice were anesthetized with ketamine/xylazine
(20%/10%, respectively) in 0.85% (w/v) saline cocktail, perfused
intracardially with 10–20 ml of artificial cerebrospinal fluid
(aCSF), and decapitated. The brain was quickly isolated
and chilled in dissecting solution. The dissecting solution
contained the following (in mM): 75 sucrose, 81 NaCl, 2.5
KCl, 1.0 NaH2PO4, 0.1 CaCl2, 4.9 MgCl2, 26.2 NaHCO3,
and 1.5 glucose (300–305 mOsm). Slices 360 µm thick were
cut using a model 300 Vibratome. Slices were incubated in
the bathing solution at 32 ± 1◦C for 30–40 min. Slices
were then stored at room temperature until transferred to a
submersion-type recording chamber after at least 80 min of
recovery following slicing. The bathing solution (regular aCSF)
contained (in mM): 124 NaCl, 3 KCl, 1.25 NaH2PO4, 2 CaCl2,
1 MgSO4, 26 NaHCO3, and 1 glucose (saturated with 95%
O2/5% CO2). Whole-cell patch-clamp recordings from striatal
tdTomato- or from eGFP-expressing MSNs were performed
using micropipettes with a resistance of 3–5 M made from
1.1/1.5 mm borosilicate glass (Sutter Instruments). Recording
pipettes were filled with the following solution (in mM): 117
Cs-methanesulphonate, 2.8 NaCl, 5 TEA-Cl, 2 QX-314 [N-(2,6-
dimethylphenylcarbamoylmethyl)triethylammonium chloride],
0.4 EGTA, 2 ATP-Mg, 0.25 GTP-Mg, 20 HEPES-CsOH (pH
7.2–7.4, 275–285 mOsm). A junction potential of 12 mV
between the internal and the external solution was calculated
theoretically (using the corresponding function in Clampfit),
corroborated empirically, and used to correct voltages online.
Access resistance was frequently checked to be <30 M and
stable (less than 20% variability). Protocols were designed
to study input/output curves, NMDA/AMPA ratio, miniature
EPSCs and, paired pulse ratio (PPR; see below). At all times, at
least five breeding pairs were kept as resource for experimental
mice. For each genotype/striatal pathway/protocol, useful data
sets were obtained from six or more mice from three or more
litters, where 1–3 cells per slice/pathway and 1–5 cells per
mouse/pathway were recorded. Results from a total of 185 WT
(91 DR1 and 94 DR2) cells and a total of 182 KO (89 DR1
and 93 DR2) cells are reported. Baseline parameters in regular
aCSF and with the Cs+-based internal solution used here did not
differ among the groups including access resistance [(DR1 cells:
17.0 ± 0.70 M, WT; 18.6 ± 0.70 M, NL1 KO, P = 0.111;
DR2 cells: 19.0 ± 0.79 M, WT; 17.8. ± 0.77 M, NL1 KO,
P = 0.361)], cell membrane resistance [(DR1 cells: 197 ± 10.3
M, WT; 229 ± 13.2 M,NL1 KO, P = 0.114; DR2 cells: 312
± 23.3 M, WT; 326 ± 23.0 M,NL1 KO, P = 0.276)], and cell
capacitance [(DR1 cells: 139 ± 4.8 PF, WT; 147 ± 4.35 PF, NL1
KO, P = 0.231; DR2 cells: 103± 3.8 PF, WT; 101.2± 3.4 PF, NL1
KO, P = 0.361)].
EPSCs were evoked (eEPSCs) by stimulating the brain at
the boundary of the corpus callosum and the dorsolateral
striatum. Stimuli were elicited for 0.2 ms using bipolar electrodes
and a model A365 battery-driven stimulus isolator (WPI). For
input/output (I/O) experiments, the lowest stimulation intensity
to elicit events in at least three out of five stimulations was
considered the threshold for the experiment. The intensity
of the stimulus was then scaled 1.5× the previous intensity
and in some experiments, up to 25.6× threshold (labeled as
‘‘Threshold Fold’’ in Figure 1C). I/O linearity was usually lost
in stimulation intensities around 17.4× threshold; therefore, I/O
analysis was done on stimulation intensities that ranged from
threshold to 11.4× threshold. Evoked NMDA/AMPA ratios were
determined using standard, published methods (Myme et al.,
2003). In the presence of picrotoxin, AMPAR currents were
measured at the peak and at a voltage of−80 mV, at which most
NMDAR currents are blocked by Mg2+. Stimulation intensities
were adjusted so the peak amplitude of the AMPA current was
maintained within the 200–600 pA (mostly within 300–500 pA)
range. NBQX (10µM), an AMPA receptor antagonist, was added
to the bath after recording AMPAR currents. In the same cell,
NMDAR currents were measured in a 2 ms window 48 ms after
stimulus onset at a voltage of +40 mV. In a subset of these
experiments Ro 25–6891 (0.5–1 µM), an antagonist of GluN2B-
containing NMDARs, was added to the bath. To determine the
current contribution of GluN2B-containing NMDARs vs. the
current contributed by putative GluN2A-containing NMDARs,
the remaining current after application of Ro 25–6891 (the
putative GluN2A component) was subtracted off-line from the
total NMDAR current to obtain the GluN2B-component. PPR
was done at two inter-event intervals (IEIs) that corresponded
to the maximal facilitation (40 ms) or the maximal depression
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FIGURE 1 | Input/output curves of glutamatergic projections onto direct
and indirect pathway MSNs are unchanged. (A) Fluorescent microscope
low power images of WT and NL1 KO mice expressing the fluorescent markers
td-Tomato (driven by the DR1 promoter, direct pathway, left panels) or EGFP
(driven by the DR2 promoter, indirect pathway, right panels). Insets show
projections of DR1 MSNs to SNr passing through the GPe (left inset) or a
strongly glowing GPe due to EGFP-expressing DR2 terminals from the striatum
(right inset). Inset on DR1 WT was taken from a different image that better
highlighted the DR1 medium spiny neuron (MSN) projections. Bar = 2 mm (0.8
mm for insets). (B) Upper panels, low power fluorescence image of a DR2
mouse showing the target site for recording MSNs (right) and schematic
showing the placement site for the stimulation electrode (left). Bottom panels,
high power infrared differential interference contrast and DOT optics (right) or
DR2-EGFP fluorescence (left) images showing the approach of a recording
pipette to an EFGP-expressing MSN. Bar = 25 µm for bottom images and 500
µm for top images. (C) Traces of evoked EPSCs (eEPSCs) elicited upon current
injections onto the EC, and recorded in whole-cell configuration in striatal
MSNs. The intensity of the stimulation, expressed as a multiple of the threshold,
is connected to the corresponding trace by an arrow. Inset. For I/O recordings,
threshold stimulation was required to be below 60 µA. Under this condition,
stimulation threshold was similar between WT and NL1 KO mice. (D) I/O curves
for the direct (left) or the indirect (right) pathways are similar between genotypes.
Labels: Ctx, cortex; EC, external capsule; St, striatum; Th, thalamus; GPe,
globus pallidus externus and SNr, substantia nigra pars reticulata.
(400 ms; Akopian and Walsh, 2007; Ding et al., 2008).
Stimulation intensities were adjusted so the peak amplitude of
the first pulse was maintained within the 150–300 pA range.
Even though stimulus intensities were intended to induce a
homogenous conditioning stimulus across groups, the resulting
peak current amplitudes for P1 differed among them (not
shown). Therefore, to cancel this artificial difference, all events
within a group were normalized to the average current amplitude
for P1. These normalized data was then used for statistical
analysis to compare P1 vs. P2 between genotypes and genders
and presented in Table 2 as normalized event amplitude 1 of
short inter-pulse interval (NE1S) vs. NE2S or as normalized event
amplitude 1 of long inter-pulse interval (NE1L) vs. NE2L. For
recording of mEPSCs, the bathing solution was supplemented
with Tetrodotoxin (0.75–1 µM) and Picrotoxin (50–100 µM).
After breaking in, the internal solution was dialyzed for at least
8 min, then cells were held at −70 mV and spontaneous mEPSC
transmission was recorded for 2–5min or until at least 200 events
were obtained.
Recordings were obtained using the 700B Multiclamp
amplifier (Molecular Devices, Sunnyvale, CA, USA), and
neurons were visualized using a Carl Zeiss Axioexaminer D1
microscope equipped with infrared differential interference
contrast, DOT optics, a CCD camera, and epifluorescence.
The fluorescence filters used were (excitation, beam splitter,
emission): set 38 (BP 470/40, FT 495, BP 525/50) for EGFP
expressing DR2 cells and, set 43 (BP 545/25, FT 570, BP 605/70)
for td-Tomato expressing DR1 cells (Carl Zeiss Microimaging
Inc., Thornwood, NY, USA). Responses were digitized at 10
kHz and filtered at 2 kHz. Data were analyzed offline using
pClamp (Molecular Devices, Sunyvale, CA, USA), Minianalysis
(Synaptosoft, Fort Lee, NJ, USA), andMicrosoft Excel, Redmond,
WA, USA.
Statistical Analysis
All statistical analyses were conducted using Statistica software
(version 5.5; Statsof, Tulsa, OK, USA) or Prism software (version
6.02; GraphPad, La Jolla, CA, USA). Statistica was used either
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for two-way ANOVAs or for three-way repeated measures
ANOVA (rmANOVA). Sex and genotype were the two factors
in two-way ANOVAs. In addition, for the three-way ANOVA,
either the stimulus threshold fold (STF; for I/O curves), or
the pulse number (for PPR) were used. If a main effect of
sex was found, the Tukey Honest Significant Difference with
unequal N (the Spjotvoll-Stoline) post hoc test was applied.
Both male and female mice were used for the experiments. For
the purpose of these studies, where the effects of constitutively
deleting the NL1 protein are central to our investigations, it
was required that the Spjotvoll-Stoline test rendered a significant
difference when comparing genders within the same genotype.
Otherwise, any statistically significant ‘‘main effect of sex’’
obtained in the analysis was considered either spurious or of little
value to understand the importance of NL1-deletion in striatal
pathophysiology. Importantly, not a single parameter fulfilled
the above requirement (see Tables 1, 2), therefore, genders
were pooled throughout this work.When appropriate, Graphpad
Prism software was used for linear regression analysis where
slope = r2 and probability are reported. For ease of flow of data
presentation, only rmANOVAs corresponding to the analysis of
I/O curves are presented as part of the main text. For the rest of
the data, average ± SEM are presented, and P values correspond
to those from the ANOVA analysis. P values between 0.1005
and 0.0504 were considered of potential interest to readers and
were included in the figures. For further reference, a complete
display of the statistical results for ANOVAs and rmANOVAs is
presented in Tables 1, 2.
Results
Strength of Glutamatergic Inputs onto MSNs
of the Direct and of the Indirect Pathways
Mice constitutively deficient in NL1 show alterations in
glutamatergic synaptic function (Chubykin et al., 2007; Blundell
et al., 2010). These mice, however, demonstrate increased
repetitive grooming behaviors that are potentially mediated
by the striatum along with a decrease in NMDA/AMPA
ratio at excitatory inputs onto striatal MSNs (MSNs; Blundell
et al., 2010). This suggests either a decrease in NMDAR-
mediated current, an increase in AMPAR-mediated current
or some combination of the two. Measuring NMDA/AMPA
ratio is also not useful for determining baseline synaptic
strength. Thus, to compare synapse strength between genotypes,
we examined input/output (I/O) curves of evoked excitatory
synaptic transmission onto both DR1 (direct pathway) and
DR2 (indirect pathway) MSNs of NL1 KO mice compared
to WT littermate controls (Figure 1A). Synaptic currents
were evoked by stimulation in the nearby corpus callosum.
Recordings were done at a membrane potential of −80 mV,
where the slowly activating NMDA receptors are blocked by
extracellular Mg2+ ions. Due to this and because current
amplitudes were determined at the peak of the eEPSCs, this
experimental protocol mainly determines the strength of AMPA
receptor signaling. Typically, stimulation thresholds to elicit a
recognizable eEPSC response in three out of five stimuli were
between the 15–30 µA. To reduce the likelihood of evoking
polysynaptic events due to stimulation of clusters of fibers distant
to the stimulating electrode, experiments with thresholds above
60 µA were not used in I/O analysis. Using these parameters,
maximum stimulation intensities never exceeded 700 µA. No
main effect of gender or of genotype was found in either pathway
(Figures 1B–D; I/O three way rmANOVA. DR1 MSNs: main
effect of sex, F(1,30) = 0.21, P = 0.652; main effect of genotype,
F(1,30) = 0.01, P = 0.937; main effect of STF, F(6,180) = 60.11,
P < 0.0001; sex × genotype interaction, F(1,30) = 3.46, P = 0.073;
sex× STF interaction, F(6,180) = 1.24, P = 0.289; genotype× STF
interaction, F(6,180) = 0.07, p = 0.999; sex × genotype × STF
interaction; F(6,180) = 2.24, P = 0.041; DR2 MSNs: main effect
of sex, F(1,33) = 0.63, P = 0.433; main effect of genotype, F(1,33)
0.09, P = 0.768; main effect of STF, F(6,198) = 43.24, P < 0.0001;
sex × genotype interaction, F(1,33) = 0.41, P = 0.529; sex × STF
interaction, F(6,189) = 0.34, P = 0.917; genotype× STF interaction,
F(6,189) = 0.05, P = 0.999; sex × genotype × STF interaction;
F(6,189) = 0.66, P = 0.686). In line with previous reports in other
brain regions on NL1 KO mice (Chubykin et al., 2007; Jung
et al., 2010; Soler-Llavina et al., 2011), these experiments suggest
that baseline, largely AMPAR-mediated glutamatergic evoked
synaptic responses are not altered in the striatum of NL1 KO
mice.
NMDA/AMPA Ratio is Selectively Reduced in the
Direct Pathway
Both intracellular and extracellular domains of NL1 are thought
to modulate clustering of NMDARs at the synapse (Barrow
et al., 2009; Budreck et al., 2013). This is in line with the strong
correlation between NMDA/AMPA ratio (recorded in cells in
culture as well as in acute slices) and NL1 expression levels
manipulated by diverse strategies. In general, overexpression
increases the NMDA/AMPA ratio whereas knockdown or
knockout strategies result in decreases in NMDA/AMPA ratio
(Chubykin et al., 2007; Futai et al., 2007; Kim et al., 2008b;
Jung et al., 2010; Soler-Llavina et al., 2011; Kwon et al., 2012;
Budreck et al., 2013). Because NL1 KO mice exhibit reduced
NMDA/AMPA ratio in MSNs in the striatum (Blundell et al.,
2010), we further examined NMDA/AMPA ratio specifically in
DR1 or in DR2 MSNs of WT and NL1 KO mice.
To limit stimulation to local fibers, stimulation intensities
were adjusted to elicit fast AMPA eEPSCs with amplitudes
between 200–600 pA (mostly between 300–500 pA). When
compared to WT littermates, NL1 KO mice showed a significant
decrease in NMDAR current amplitude (WT, 380 ± 28.2 pA,
n = 32, vs. KO, 274 ± 21.2 pA, n = 33, P = 0.001) and in
NMDA/AMPA ratio (WT, 1.01 ± 0.07, n = 32, vs. KO, 0.78 ±
0.06, n = 33, P = 0.006) on direct pathway MSNs. In contrast,
neither a change in NMDAR current amplitude (WT, 328 ±
19.5 pA, n = 28, vs. KO, 311 ± 28.7 pA, n = 29, P = 0.283),
nor in NMDA/AMPA ratio (WT, 0.88 ± 0.06, n = 28, vs. KO,
0.83 ± 0.08, n = 29, P = 0.167), was observed on DR2 MSNs
(Figures 2A,B). Regression analysis further confirms no impact
of the amplitude of the AMPA eEPSC on the NMDA/AMPA
ratio under any condition (Figure 2C; Linear Regression. DR1
WT; slope = −0.21 ± 0.47, r2 = 0.006, F(1,30) = 0.184, p = 0.671;
DR1 KO; slope = −0.52 ± 0.32, r2 = 0.077, F(1,31) = 2.57; DR2
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TABLE 1 | Analysis of variance for electrophysiological studies.
Parameter Comparison Results
I/O Direct; WT n = 19, KO n = 16
Sex and Genotype
and Stimulus Threshold
Fold (STF)
3-way rmANOVA; Main effect of sex, F(1,30) < 0.21, p < 0.652; main effect of genotype,
F(1,30) < 0.01, p < 0.937; main effect of stimulus threshold fold (STF), F(6,180) < 60.11,
p < 0.0001; sex × genotype interaction, F(1,30) < 3.46, p < 0.073; sex × STF interaction,
F(6,180) < 1.24, p < 0.289; genotype × STF interaction, F(6,180) < 0.07, p < 0.999; sex ×
genotype × STF interaction; F(6,180) < 2.24, p < 0.041
I/O Indirect; WT n = 20, KO n = 22
Sex and Genotype and
STF
3-way rmANOVA; Main effect of sex, F(1,33) < 0.63, p < 0.433; main effect of genotype,
F(1,33) < 0.09, p < 0.768; main effect of stimulus threshold fold STF, F(6,198) < 43.24,
p < 0.0001; sex × genotype interaction, F(1,33) < 0.41, p < 0.529; sex × STF interaction,
F(6,189) < 0.34, p < 0.917; genotype × STF interaction, F(6,189) < 0.05, p < 0.999; sex ×
genotype × STF interaction; F(6,189) < 0.66, p < 0.686
NMDAR Current; Direct WT n = 31,
KO n = 33
NMDAR current Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,61) < 0.07, p < 0.799; main effect of genotype,
F(1,61) < 11.86, p < 0.001; sex × genotype interaction, F(1,61) < 4.05, p < 0.049;
NMDA/AMPA ratio Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,61) < 0.004, p < 0.948; main effect of genotype,
F(1,61) < 8.12, p < 0.006; sex × genotype interaction, F(1,61) < 6.54.05, p < 0.013
NMDAR Current; Indirect WT n = 29,
KO n = 31
NMDAR current Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,59) < 1.48, p < 0.2293; main effect of genotype,
F(1,59) < 1.18, p < 0.28; sex × genotype interaction, F(1,59) < 1.57, p < 0.216
NMDA/AMPA ratio Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,59) < 0.62, p < 0.434; main effect of genotype,
F(1,59) < 1.96, p < 0.167; sex × genotype interaction, F(1,61) < 1.34, p < 0.258
NMDAR Charge transfer (Q); Direct
WT n = 20, KO n = 21
Total NMDAR Q Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 2.18, p < 0.148; main effect of genotype,
F(1,59) < 7.78, p < 0.008; sex × genotype interaction, F(1,59) < 0.64, p < 0.429
GluN2A Q Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 5.0, p < 0.031; main effect of genotype,
F(1,39) < 7.80, p < 0.008; sex × genotype interaction, F(1,39) < 0.13, p < 0.726
GluN2B Q Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 0.01, p < 0.933; main effect of genotype,
F(1,39) < 3.04, p < 0.089; sex × genotype interaction, F(1,39) < 1.20, p < 0.281
NMDAR Q; Indirect WT n = 21, KO
n = 23
Total NMDAR Q Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 0.17, p < 0.687; main effect of genotype,
F(1,59) < 2.51, p < 0.121; sex × genotype interaction, F(1,59) < 0.90, p < 0.348
GluN2A Q Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 0.53, p < 0.473; main effect of genotype,
F(1,39) < 1.13, p < 0.295; sex × genotype interaction, F(1,39) < 0.34, p < 0.561
GluN2B Q Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 0.01, p < 0.931; main effect of genotype,
F(1,39) < 2.52, p < 0.120; sex × genotype interaction, F(1,39) < 5.23, p < 0.028
Miniature neurotransmission direct;
WT n = 18, KO n = 18
Amplitude Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,32) < 0.003, p < 0.954; main effect of genotype,
F(1,32) < 1.32, p < 0.260; sex × genotype interaction, F(1,32) < 0.18, p < 0.673
Frequency Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,32) < 3.50, p < 0.070; main effect of genotype,
F(1,32) < 0.15, p < 0.697; sex × genotype interaction, F(1,32) < 1.82, p < 0.186
Miniature neurotransmission indirect;
WT n = 20, KO n = 20
Amplitude Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,32) < 3.96, p < 0.054; main effect of genotype,
F(1,32) < 3.04, p < 0.090; sex × genotype interaction, F(1,32) F(1,36) < 0.05, p < 0.831
Frequency Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,32) < 0.187, p < 0.668; main effect of genotype,
F(1,32) < 5.67, p < 0.023; sex × genotype interaction, F(1,32) F(1,36) < 0.03, p < 0.860
PPR Direct; WT n = 20, KO n = 20
Norm P1 vs. Norm P2 (IEI 400 ms) Sex and Genotype
and pulse # (P)
3-way ANOVA; Main effect of sex, F(1,36) < 1.87, p < 0.180; main effect of genotype,
F(1,36) < 0.29, p < 0.593; main effect of P, F(6,180) < 251.4, p < 0.0001; sex × genotype
interaction, F(1,36) < 0.299, p < 0588; sex × P interaction, F(1,36) < 5.79, p < 0.021;
genotype × P interaction, F(2,36) < 0.29, p < 0.594; sex × genotype × P interaction;
F(1,36) < 0.1, p < 0.752
Norm P1 vs. Norm P2 (IEI 40 ms) Sex and Genotype
and P
3-way ANOVA; Main effect of sex, F(1,36) < 0.03, p < 0.876; main effect of genotype,
F(1,36) < 1.01, p < 0.321; main effect of P, F(6,180) < 9.55, p < 0.004; sex × genotype
interaction, F(1,36) < 0.05, p < 0.889; sex × P interaction, F(1,36) < 0.10, p < 0.756; genotype
× P interaction, F(1,36) < 3.48, p < 0.070; sex × genotype × P interaction; F(1,36) < 0.08,
p < 0.780
(Continued)
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TABLE 1 | (Continued).
Parameter Comparison Results
P1 P2 (IEI 400 ms) Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 6.93, p 0.012; main effect of genotype,
F(1,39) < 0.181, p < 0.187; sex × genotype interaction, F(1,39) < 0.05, p < 0.824
P1 P2 (IEI 40 ms) Sex and genotype 2-way ANOVA; Main effect of sex, F(1,39) < 0.001, p < 0.973; main effect of genotype,
F(1,39) < 1.01, p < 0.321; sex × genotype interaction, F(1,32) < 0.17, p < 0.682
PPR Indirect; WT n = 19, KO n = 21
Norm P1 vs. Norm P2 (IEI 400 ms) Sex and Genotype
and pulse # (P)
3-way ANOVA; Main effect of sex, F(1,36) < 0.04, p < 0.834; main effect of genotype,
F(1,36) < 0.02, p < 0.904; main effect of P, F(6,180) < 102.73, p < 0.0001; sex × genotype
interaction, F(1,36) < 0.01, p < 0.929; sex × P interaction, F(1,36) < 0.72, p < 0.400; genotype
× P interaction, F(2,36) < 0.20, p < 0.656; sex × genotype × P interaction; F(1,36) < 0.14,
p < 0.714
Norm P1 vs. Norm P2 (IEI 40 ms) Sex and Genotype
and P
3-way ANOVA; Main effect of sex, F(1,30) < 0.12, p < 0.728; main effect of genotype,
F(1,30) < 0.13, p < 0.717; main effect of P, F(6,180) < 25.46, p < 0.001; sex × genotype
interaction, F(1,36) < 0.51, p < 0.479; sex × P interaction, F(1,36) 2.36, p < 0.134; genotype
× P interaction, F(2,36) < 2.42, p < 0.129; sex × genotype × P interaction; F(1,36) < 9.13,
p < 0.004
P1 P2 (IEI 400 ms) Sex and Genotype 2-way ANOVA; Main effect of sex, F(1,39) < 0.50, p < 0.485; main effect of genotype,
F(1,39) < 1.05, p < 0.313; sex × genotype interaction, F(1,39) < 0.04, p < 0.547
P1 P2 (IEI 40 ms) Sex and genotype 2-way ANOVA; Main effect of sex, F(1,39) < 3.23, p < 0.081; main effect of genotype,
F(1,39) < 2.09, p < 0.157; sex × genotype interaction, F(1,39) < 6.25, p < 0.017
Either 2-way ANOVAs (for glutamatergic currents and charge transfer, and for NMDA/AMPA ratios and P2/P1 ratios between genotypes) or 3-way ANOVAs with repeated
measures (for I/O curves or for comparison of P1 vs. P2 amplitude within genotypes) were used. Between-subjects factors are generally sex and genotype, with repeated
measures (pulse number either in the I/O curves or in PPR). F(x, y), F ratio statistic is used to determine whether the variances in two independent samples are equal; x, y
are degrees of freedom. Degrees of freedom is a measure of the number of independent pieces of information on which the precision of a parameter estimate is based.
x, Number of groups −1; y, number of animals per group −1, multiplied by the number of groups.
WT; slope = −0.62 ± 0.31, r2 = 0.136, F(1,26) = 0.4.09, p = 0.535;
DR2 KO; slope = −0.62 ± 0.37, r2 = 0.092, F(1,27) = 2.73,
P = 0.110).
The Reduction in NMDAR Currents in the Direct
Pathway is Mainly Driven by Decreased GluN2A
Currents
NMDARs are heterotetramers composed of two GluN1 subunits
and two GluN2 or GluN3 subunits (Kutsuwada et al., 1992; Das
et al., 1998; Laube et al., 1998). There are four isoforms for GluN2
(GluN2A-D) that have distinctive biophysical and physiological
properties (Köhr et al., 2003; Massey et al., 2004; Erreger et al.,
2005; Kim et al., 2005; Foster et al., 2010;Wyllie et al., 2013). Only
Glun2A and GluN2B are detected at significant levels in MSNs in
the striatum (Landwehrmeyer et al., 1995; Kuppenbender et al.,
2000; Dunah and Standaert, 2003). Recent evidence suggests that
these subunits have a divergent influence on striatal physiology
and on correlated behaviors (Fantin et al., 2007; Sarre et al., 2008;
Schotanus and Chergui, 2008; Mabrouk et al., 2013).
To further unravel the possible physiological impact of
the reduced NMDAR currents in the striatum of NL1 KO
mice, we determined if this alteration is selective for GluN2A-
vs. GluN2B-containing NMDARs. After recording baseline
NMDAR currents, in a subset of experiments we applied a
GluN2B-containing NMDAR selective inhibitor Ro 25–6891
(Ro, 1 µM; Fischer et al., 1997; Mutel et al., 1998). NMDAR
currents resistant to Ro, considered here as currents driven by
putative GluN2A-containing NMDARs, were then subtracted
from the total NMDAR current. The resulting Ro-sensitive
component was considered to be driven by GluN2B-containing
NMDARs (Figure 3A). As for initial NMDAR current amplitude
(Figure 2), the conclusion that NMDAR function is reduced in
the direct pathway of NL1 KO mice was also supported when
considering total NMDAR charge transfer (Q) (Figure 3B; WT,
62 ± 5.0 nC, n = 19, vs. KO, 41 ± 3.2 nC, n = 20, P = 0.008).
This reduction in NMDAR function was driven mainly by a
reduction in GluN2A Q (WT, 35 ± 3.6 nC, n = 19, vs. KO, 20
± 2.5 nC, n = 20, P = 0.008), but not GluN2B Q (WT, 27 ± 2.4
nC, n = 19, vs. KO, 21 ± 2.2 nC, n = 20, P = 0.089). Again, as
for the NMDA/AMPA ratio, DR2 MSNs between WT and NL1
KO littermates showed no significant difference either in total
NMDAR Q (Figure 3B; WT, 57 ± 4.9 nC, n = 21, vs. KO, 48
± 4.2 nC, n = 22, P = 0.121), in Q driven by GluN2A-containing
NMDARs (WT, 29± 2.4 nC, n = 21, vs. KO, 23± 2.5 nC, n = 22,
P = 0.295), or in Q driven by GLUN2B-containing NMDARs
(WT, 29± 2.5 nC, n = 21, vs. KO, 23± 2.4 nC, n = 22, P = 0.120),
although a ‘‘genotype× sex’’ interaction for GluN2B was present
(see Table 1).
GluN2A-containing NMDARs have a higher affinity
for glutamate than GluN2B-containing NMDARs (Erreger
et al., 2005). In general, their subcellular localization is
also different; GluN2A-containing NMDARs are mainly
synaptic, whereas GluN2B-containing NMDARs are the
predominantly extrasynaptic NMDARs but are also expressed
at significant levels at the synapse (Steigerwald et al., 2000;
Brickley et al., 2003; Townsend et al., 2003; Kopp et al., 2007).
Therefore, the proportion of Glun2A vs. GluN2B-containing
NMDARs that are activated can differ depending on the
amount of neurotransmitter released. At low neurotransmitter
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TABLE 2 | Probability summary of main effect of sex on NL1KO physiology.
DR1 DR1 post hoc Spjotvoll-Stoline test DR2
Parameter All WT KO All
M vs. F M vs. F
I/O 0.652 − − 0.433
NMDAR current 0.799 − − 0.229
NMDA/AMPA ratio 0.948 − − 0.434
NMDA Q 0.148 − − 0.687
GluN2A Q 0.031 0.612 0.297 0.473
GluN2B Q 0.933 − − 0.931
Mini Amp 0.954 − − 0.054
Mini Freq 0.070 − − 0.668
PPR: NP1S vs. NP2S 0.875 − − 0.727
PPR: P1S/P2S 0.973 − − 0.081
PPR: NP1L vs. NP2L 0.180 − − 0.834
PPR: P1L/P2L 0.012 0.381 0.198 0.313
The Spjotvoll-Stoline post hoc test for unequal ns was performed on parameters that showed a main effect of sex in the ANOVAs. However, when genders within a
genotyped were compared, no significant difference was found, therefore, genders were pooled. NPS, Normalized Event Amplitude, Short Interpulse Interval (40 ms).
NPL, Normalized Event Amplitude, Long Interpulse Interval (400 ms).
concentrations, synaptic (i.e., mainly GluN2A- but also Glun2B-
containing) receptors will be activated, but at strong enough
stimulation intensities, glutamate spillover and activation of
GluN2B-containing NMDARs may predominate (Kullmann and
Asztely, 1998; Carter and Regehr, 2000; Chalifoux and Carter,
2011).
To investigate if this could be happening in our recording
conditions, we performed regression analysis comparing the
total NMDAR Q among all experiments within the same
genotype and pathway to the Q fraction of their corresponding
GluN2A or GluN2B components. This analysis indicated no
correlation between normalized total NMDAR and the Q
fraction driven by either GluN2A- or GluN2B-containing
NMDARs, indicating that significant differences in the relative
amount of neurotransmitter released among these experiments
(partially reflected in the size of the total NMDAR Q) do
not exist, and, therefore, do not drive our main observation
(Figure 3C, Linear Regression of normalized GluN2A Q vs.
total NMDA Q. DR1 WT; slope = 0.20 ± 0.15, r2 = 0.075,
F(1,20) = 1.618, P = 0.218; DR1 KO; slope = 0.09 ± 0.16,
r2 = 0.017, F(1,19) = 0.319, P = 0.579; DR2 WT; slope = −0.76
± 0.12, r2 = 0.020, F(1,19) = 0.394, P = 0.538; DR2 KO;
slope = −0.10 ± 0.20, r2 = 0.014, F(1,18) = 0.268, P = 0.611);
Linear Regression of normalized GluN2B Q vs. total NMDA
Q. DR1 WT; slope = −0.20 ± 0.15, r2 = 0.075, F(1,20) = 1.638,
P = 0.215; DR1 KO; slope = −0.09 ± 0.16, r2 = 0.016,
F(1,19) = 0.315, P = 0.581; DR2 WT; slope = 0.76 ± 0.12,
r2 = 0.020, F(1,19) = 0.394, P = 0.538; DR2 KO; slope = −0.10
± 0.20, r2 = 0.015, F(1,18) = 0.268, P = 0.611).
The Frequency of Spontaneous mEPSC
Neurotransmission is Reduced in the Indirect
Pathway of NL1KO Mice
In vitro and in vivo experimental procedures that affect NL1
expression levels can impact spontaneous miniature excitatory
neurotransmission (Prange et al., 2004; Nam and Chen,
2005; Chen et al., 2010; Mondin et al., 2011; Burton et al.,
2012; Kwon et al., 2012). Furthermore, studies in cortex and
hippocampus have shown that NL1 levels modulate synaptic
vesicle accumulation and neurotransmission (Wittenmayer et al.,
2009; Stan et al., 2010), and synaptic release probability (Futai
et al., 2007). Thus, we reasoned that constitutive deletion of NL1
may affect spontaneous miniature excitatory neurotransmission
in the striatum. To investigate this, we compared the properties
of miniature excitatory synaptic transmission in both DR1 and
DR2 MSN pathways between NL1 KO and WT mice. NL1 KO
mice showed no difference in mEPSC neurotransmission in
the direct pathway (WT amplitude, 10.3 ± 0.34 pA, n = 18
vs. KO amplitude, 11 ± 0.48 pA, n = 18, P = 0.850; WT
frequency, 6.1 ± 0.70 Hz, n = 18 vs. KO frequency, 5.5 ±
0.76 Hz, n = 20, P = 0.755). The lack of mEPSC amplitude
difference is consistent with our conclusion that the direct
pathway alterations in NMDA/AMPA ratio are mediated by
altered NMDAR-mediated currents as no change in the largely
AMPAR-mediated mEPSC was identified. However, mEPSC
frequency was reduced in the indirect pathway (Figures 4A,B;
WT frequency, 5.6 ± 0.92 Hz, n = 20; KO frequency, 3.1
± 0.40 Hz, n = 20, P = 0.023). A small change was also
observed in the amplitude in the indirect pathway, but it
did not reach statistical significance (WT amplitude, 10.7 ±
0.53 pA, n = 20 vs. KO amplitude, 9.6 ± 0.33 pA, n = 20,
P = 0.090).
Marginal Differences in Paired Pulse Facilitation
in NL1 KO Mice
A reduction in miniature frequency may be related to a decrease
in release probability of synaptic vesicles. PPR is frequently used
as an initial approach to investigate changes in the probability
of neurotransmitter release (Salin et al., 1996; Kaplan et al.,
2003). PPR is studied by pairing two stimuli of the same inputs
with specific, brief inter-stimulus intervals (inter-event interval,
IEI). Our unpublished data and those reported by other groups
(Akopian and Walsh, 2007; Ding et al., 2008) indicate that
stimulation of glutamatergic afferents to the striatum at short
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FIGURE 2 | NL1 KO mice show a DR1 specific reduction in NMDAR
neurotransmission. (A) eEPSCs were elicited as in Figure 1 but AMPAR
current peak was required to be in the range of 200–600 pA. Traces of WT
(black) or KO (gray) mice were superimposed. The amplitude of AMPAR
current for the trace corresponding to the DR1-WT cell was 522 pA. The
amplitude of the AMPAR current for all other cells in this figure were scaled to
that of DR1-WT and all NMDAR currents were proportionally scaled. Actual
amplitudes for scaled-AMPAR currents in this figure were: 437 pA, 378 pA
and 404 pA, for DR1-NL1 KO, DR2-NL1 WT and DR2-NL1 KO cells,
respectively. Vertical bar = 250 pA. (B) Bar graphs of current amplitudes (left)
for AMPARs and NMDARs or for the NMDA/AMPA ratio (right). NL1 KO mice
showed a deficit in NMDAR currents, as well as a reduction in the
NMDA/AMPA ratio, but only in the direct pathway. **p < 0.01, ***p < 0.001.
(C) Regression analysis of normalized AMPAR currents vs. the NMDA/AMPA
ratio. AMPAR currents of NL1 KO mice were normalized to the maximal peak
current for their WT control group within the direct or indirect pathway. The
NMDA/AMPA ratio showed no significant correlation to the normalized
amplitude of the AMPAR current.
IEIs (i.e., 30–70ms) induce amild facilitation whereas depression
is recorded at IEIs above 150 ms. Within the same PPR protocol,
here we used IEI 400 ms (in odd sweeps) and IEI 40 ms (in even
sweeps) because they elicit themaximum levels of depression and
of facilitation, respectively.
To determine if PP facilitation (PPF) or PP depression (PPD)
existed within a group, we first compared currents elicited
by pulse 1 and 2 for each IEI, followed by comparison of
PPRs between groups. Both, DR1 and DR2 pathways showed
significant levels of depression at the IEI of 400 ms (DR1 WT-
P1, −197 ± 6.9 pA, vs. DR1 WT-P2, −153 ± 6.3 pA, n = 20,
P < 0.001; DR1 KO-P1, −222 ± 7.1 pA vs. DR1 KO P2, −166
± 4.8, P < 0.001, n = 20; DR2 WT-P1, −210 ± 6.1 pA vs. DR2
FIGURE 3 | Reduction in NMDAR currents is mainly due to a decrease
in GluN2A currents. (A) AMPA receptor currents were blocked with the
antagonist 5 µM NBQX (left). Afterwards, baseline NMDAR currents were
recorded at +40mV followed by the application of 0.5–1 µM Ro25–6891 (a
GluN2B antagonist, right). The remaining current (blue trace) is considered to
be driven by NMDARs containing GluN2A subunits. To estimate the
contribution of GluN2B subunits to the total NMDAR current, the GluN2A
component was subtracted from the total. The difference (red trace) was
considered to be driven by GluN2B. (B) Left panel. Integration of total NMDAR
current confirmed the selective reduction in this conductance in the direct
pathway. Middle and right panels. In the direct pathway, GluN2A was
significantly reduced whereas GluN2B shows a trend towards reduction.
Instead, in the indirect pathway neither conductance showed significant
changes. **p < 0.01. (C) Regression analysis of NMDAR currents (normalized)
vs. the fraction of GluN2A (left) or the fraction GluN2B (right). NMDAR currents
were normalized to the maximal peak current for their WT control group within
the direct and indirect pathways. No significant correlation was found between
the amplitude of the normalized NMDAR current and the fraction contributed
by GluN2A or GluN2B currents in either pathway.
WT-P2, −161 ± 5.8 pA, n = 20, P < 0.001; DR2 KO-P1, −196
± 17.6 pA vs. DR2 K0-P2, −153 ± 13.3, n = 20, P < 0.001).
When considering the PPR at this IEI, no difference between
genotypes was observed (Figures 4C,D; DR1 WT, −0.78 ± 0.02
pA, n = 20 vs. DR1 KO, −0.75 ± 0.01 pA, n = 20, P = 0.592;
DR2 WT, −0.77 ± 0.03 pA, n = 19, vs. DR2 KO, −0.80 ± 0.02
pA, n = 21, P = 0.485). Again, at the short IEI of 40 ms, both
genotypes showed similar results (i.e., facilitation) in the DR2
pathway (WT P1, −207 ± 5.7 pA vs. WT P2, −225 ± 10.5 pA,
n = 19, P = 0.011; KO P1, −224 ± 7.6 pA vs. KO P2 −231
± 8.8, n = 20, P < 0.001), with no difference in PPR between
genotypes (WT, −1.09 ± 0.05 pA, n = 20, vs. KO, 1.17 ± 0.04
pA, n = 21, P = 0.157). On the contrary, in the DR1 pathway,
WT mice showed significant facilitation at 40 ms IEI, but not
NL1 KO (WT P1, −197 ± 6.9 pA vs. WT P2 −223 ± 10.5 pA,
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FIGURE 4 | Characteristics of spontaneous miniature
neurotransmission and short-term plasticity in the direct and
indirect pathway MSNs of NL1 KO mice. (A) In the presence of
picrotoxin (75–100 µM) and of Tetrodotoxin (0.75–1 µM), spontaneous
miniature neurotransmission was recorded. After the membrane patch
was broken by suction, the pipette intracellular solution was dialyzed for
8–10 min and recordings were taken for 2–5 min in order to observe at
least 200 events per recorded neuron. The upper 2 traces and the lower
2 traces correspond to a 2 s segment recorded in the direct pathway or
in the indirect pathway, respectively. The size and number of events look
similar between genotypes in DR1 neurons, however, DR2 neurons show
fewer events in NL1 KO mice. (B) DR2 neurons of NL1 KO mice show
increased IEI (bottom right panel) reflected as an approximately 2-fold
reduction in the frequency of mini events (inset). Cumulative distributions
for amplitudes and for inter-event intervals (IEIs) were built with exactly
200 events per experiment to avoid distribution bias by experiments with
higher number of events. (C) paired pulse ratio (PPR) average traces at
IEIs of 40 ms or 400 ms. Downward deflections for stimulation # 1 for
both IEIs are superimposed, therefore, only one event is apparent. The
current relaxation after the peak for stimulus # 1 (P1) at 400 ms was
used to determine the baseline level (BL) for stimulation # 2 (P2) at both
IEI 40 ms and IEI 400 ms (P2–40 and P2–400, respectively). Peak
amplitude of P2–40 was calculated by subtracting the amplitude of the
BL at the time of the peak of P2 (BL 40) from its absolute amplitude.
BL400 was taken as the average current amplitude of a 2 ms window
just before P2- 400 was triggered. Similarly, peak amplitude for P2–400
was calculated by subtracting BL400 from the absolute peak value for
the corresponding event. The dashed-dotted line at the top corresponds
to the steady-state baseline. Dotted lines in both P2s correspond to their
recalculated amplitudes after baseline subtraction. (D) No significant
changes in PPR were identified between genotypes in either pathway,
though a trend is apparent in DR1 neurons at IEI of 40 ms. *P < 0.05.
P = 0.002, n = 20; KO P1,−224± 7.6 pA vs. KO P2,−231± 8.8,
n = 20, P = 0.355). However, when PPRs were compared between
WT and KO at this short interval, no significance (although a
trend) was reached in the DR1 pathway (WT, −1.14 ± 0.05 pA,
n = 20, vs. DR1 KO, 1.04 ± 0.03 pA, n = 21, P <= 0.065). These
findings suggest no alterations in presynaptic release probability
to explain the altered mEPSC frequency in the indirect pathway.
The PPR experiments described above were conducted in
regular aCSF, where a marginal difference if any between
genotypes was found in the direct pathway. To further the
chances of unmasking release probability differences between
genotypes, additional paired experiments at three concentrations
of Ca2+ ([Ca2+]e) were performed (Figures 5A,B). The [Ca2+]e
used were 0.6, 1.5 and 2.9 mM. Because regular aCSF contains
2 mM Ca2+ and 1mM Mg2+, [Mg2+]e was varied to keep
the total divalent concentration constant at 3 mM. Also, given
that significant NMDAR currents are observed at the highest
[Ca2+]e (2.9 mM), where [Mg2+]e is only 0.1 mM, (2R)-amino-
5-phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate
(APV) 75–100 µM was included in the bathing solutions.
Importantly, as shown in previous reports, APV did not affect
PPF nor PPD by itself, suggesting that NMDARs are not involved
in these phenomena (not shown). As expected, in the long IEI
interval (400 ms), PPD increased with [Ca2+]e (DR1 WT PPR
low, 0.99 ± 0.042; medium, 0.89 ± 0.026; high, 0.77 ± 0.028;
n = 11, P < 0.001. DR1 KO PPR low, 1.00 ± 0.058; medium,
0.83 ± 0.023; high, 0.73 ± 0.029; n = 13, P < 0.001. DR2 WT
PPR low, 0.98 ± 0.046; medium, 0.83 ± 0.025; high, 0.76 ±
0.012; n = 14, P < 0.001. DR2 KO PPR low, 0.95 ± 0.041;
medium, 0.83± 0.024; high, 0.77± 0.030; n = 12, P< 0.001), but
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FIGURE 5 | Short-term plasticity in the direct and indirect pathway
MSNs of NL1 KO mice at various divalent concentrations. (A) Main
traces, similar conditions as in Figure 1 but at low (0.6 mM), medium
(1.5 mM) and high (2.9 mM) [Ca2+]e. To maintain total divalent concentration
constant, Mg2+ concentrations were (in mM); 2.4, 1.5 and 0.1, respectively.
The peak amplitude of P1 as well as PP Depression (PPD) at IEI 400 ms
showed a strong positive correlation to [Ca2+]e. Instead, after normalizing
traces at IEI 40 ms (inset), it is evident that PP Facilitation (PPF) showed an
inverted relation to [Ca2+]e, that is, the larger the [Ca2+]e, the smaller the PPF.
(B) As expected, repeated measures ANOVA showed a strong effect of
[Ca2+]e, on PPF and on PPD on both genotypes, but no significant changes in
PPR between genotypes in either IEI and pathway were found. ###P < 0.001.
the repeated measures ANOVA yielded no significant difference
between genotypes (P = 0.691, for DR1 pathway; and, P = 0.776,
for DR2 pathway). At IEI 40 ms, PPF was inversely correlated
with [Ca2+]e (DR1 WT PPR low, 1.51 ± 0.104; medium, 1.17
± 0.037; high, 1.02 ± 0.036; n = 11, P < 0.001. DR1 KO PPR
low, 1.74 ± 0.138; medium, 1.24 ± 0.052; high 1.00 ± 0.036;
n = 13, P < 0.001. DR2 WT PPR low, 1.71 ± 0.144; medium,
1.21 ± 0.057; high, 0.99 ± 0.046; n = 14, P < 0.001. DR2 KO
PPR low, 1.84± 0.119; medium, 1.29± 0.088; high 0.99± 0.042;
n = 12, P < 0.001.), but, again, no difference was found between
genotypes (P = 0.302, for DR1 pathway; and, P = 0.773, for DR2
pathway). Overall, the lack of significant alterations in PPR across
genotypes in both direct and indirect pathways suggests that the
decrease observed in the indirect (D2) MSNmEPSC frequency is
not likely due to alterations in probability of release.
Discussion
Our findings suggest a decrease in NMDAR-mediated synaptic
transmission in NL1 KO mice that is selective for DR1 (direct
pathway) MSNs. More specifically, the reduction of NMDAR
currents in DR1 neurons is mainly due to decreased currents
driven by NMDARs containing the GluN2A subunit, although
a trend in reduced currents from GluN2B containing NMDARs
is also present. These findings confirm and extend our previous
report on an overall decrease in NMDA/AMPA ratio in the total
pool of striatal MSNs (Blundell et al., 2010). Additionally, we also
show that mEPSC frequency is reduced in the indirect pathway
with no change in PPR.
While it is clear that NMDAR-mediated currents are
decreased in the direct pathway of NL1 KO mice and the
mechanism of this decrease is due to alterations in GluN2A
containing receptors, the molecular mechanisms involved in the
reduction of NMDAR/GluN2A currents in the direct pathway
in NL1 KO mice remain uncertain. That said, several lines
of evidence suggest that NL1 modulates NMDAR function at
excitatory synapses. First, NL1 is preferentially, if not uniquely,
localized to excitatory synapses (Song et al., 1999; Chubykin
et al., 2007; Dahlhaus et al., 2010). Second, NL1 has been shown
to have indirect (through PSD-95; Irie et al., 1997; Prange
et al., 2004; Gerrow et al., 2006; Barrow et al., 2009) and,
direct (through an extracellular domain) physical interaction
with NMDARs (Budreck et al., 2013). These interactions have
been shown to be important to induce and stabilize clusters of
NMDARs at the synapse, both during development and during
adulthood, and may favor the lateral movement of NMDARs
from extrasynaptic to synaptic locations upon use-dependent
blockage of synaptic NMDARs (Tovar and Westbrook, 2002;
Budreck et al., 2013). Third, manipulations of NL1 expression
levels do indeed demonstrate a strong positive correlation with
the amplitude of NMDAR currents and with the NMDA/AMPA
ratio in other brain regions and neurons (Chubykin et al., 2007;
Futai et al., 2007; Kim et al., 2008b; Jung et al., 2010; Soler-
Llavina et al., 2011; Kwon et al., 2012; Budreck et al., 2013).
These data strongly suggest that the levels of NMDAR currents
are in part controlled by NL1 without a concomitant alteration
of AMPAR currents. However, when NL1 is overexpressed,
changes in NMDAR currents do not always correlate with similar
changes in NMDA/AMPA ratio because AMPAR currents
are also increased (Futai et al., 2007; Shipman et al., 2011;
Schnell et al., 2012; Shipman and Nicoll, 2012). Also, in some
of these reports, the changes in both AMPA and NMDAR-
mediated currents were in line with changes in the number of
synapses (Shipman et al., 2011; Schnell et al., 2012; Shipman
and Nicoll, 2012), suggesting that the changes in synaptic
currents were in part a reflection of the changes in synapse
number.
In our study, we identified decreased NMDAR currents
only in D1 MSNs of the direct pathway but no alterations
in mEPSC frequency in the direct pathway to suggest altered
synapse number, and no change in mEPSC amplitude to suggest
alterations in AMPAR-mediated synaptic responses. Likewise,
we identified no alterations in D1 MSN input/output curves
to suggest decreased synapse number. This is in line with our
previous report regarding synapse numbers in hippocampus
(Blundell et al., 2010) and from another group in cortex (Kwon
et al., 2012), where constitutive loss of NL1 did not induce a
decrease in synapse number. Thus, it appears that NL1 deletion
can selectively alter NMDAR-mediated currents in MSNs of the
direct pathway. This effect is largely mediated by alterations in
NMDARs containing GluN2A subunits. The mechanism of this
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effect as well as its selectivity for direct pathway MSNs and
for GluN2A-containing NMDARs is of great interest for future
studies.
There are numerous potential explanations for the synapse
specificity of the effects of NL1 KO. In NL1 KO mice, the
effect of constitutively ablating NL1 expression could differ
among glutamatergic synapses onto the direct pathway vs.
glutamatergic synapses onto the indirect pathway, perhaps due
to differences among these synapses in the expression of specific
presynaptic neurexins, of leucine-rich repeat transmembrane
protein isoforms (LRRTMs), or of other neuroligins that
compete with NL1 for neurexin binding (Ko et al., 2009a;
Linhoff et al., 2009; Shipman et al., 2011; Soler-Llavina
et al., 2011). Furthermore, differential expression of NL1 and
its partners/competitors among different synapses could also
explain the selective effects that manipulating NL1 expression
levels have on plastic properties observed in glutamatergic inputs
to the amygdala from cortex vs. those from the thalamus (Jung
et al., 2010), as well as the differences in levels of glutamatergic
currents and on plastic properties between CA1 and dentate
gyrus neurons in the adult hippocampus (Shipman and Nicoll,
2012). In line with the idea that expression levels of some
synaptic proteins vary between direct and indirect pathways,
differential mRNA expression levels between striatonigral MSNs
and striatopallidal MSNs has been shown for Nxn1 (Lobo et al.,
2006) as well as for NL3 (Rothwell et al., 2014).
Striatal synaptic NMDAR currents and/or the NMDA/AMPA
ratio are also affected in other animal models of ASD and
obsessive compulsive disorder (OCD; Welch et al., 2007; Peça
et al., 2011; Kouser et al., 2013). This reduction in NMDAR
currents can correlate with a reduction in NMDAR subunit
protein levels in total brain extracts (Peça et al., 2011). Similarly,
a generalized increase in the levels of GluN1 or GluN2 subunits
is induced upon NL1 overexpression (Budreck et al., 2013;
Hoy et al., 2013), supporting the idea that the size of synaptic
NMDAR currents can correlate with a generalized alteration
of NMDAR expression levels. In stark contrast, no reduction
in the levels of NMDAR subunits due to constitutive loss of
NL1 in vivo has been demonstrated to our knowledge. For
example, in spite of a reduction of NMDAR currents in NL1
KO mice (Blundell et al., 2010; Budreck et al., 2013), no changes
in levels of these subunits were demonstrated either in total
brain homogenates or in biotinylated surface proteins. Together,
this evidence suggests that mechanisms other than protein
expression levels are involved in the reduction of NMDAR
currents in NL1 KOmice. Budreck et al. (2013) indicate that NL1
and NMDARs directly interact through extracellular domains.
This interaction seems to be important for the recruitment of
extrasynaptic NMDARs into the synapse, stabilizing clusters of
synaptic NMDARs without significantly affecting total NMDAR
expression levels or synapse numbers (Budreck et al., 2013).
Additionally, constitutive loss of NL1 may induce other type
of posttranslational modifications that impact NMDAR channel
function that could contribute to reduce NMDAR currents
without affecting NMDAR expression levels.
We and others have demonstrated altered mEPSC synaptic
transmission in response to experimental manipulations
that modify the expression levels of NL1. In general, NL1
overexpression increases mEPSC frequency, whereas NL1
ablation, knockdown, or expression of dominant-negative NL1,
decreases it (Prange et al., 2004; Nam and Chen, 2005; Chen
et al., 2010; Mondin et al., 2011; Burton et al., 2012; Kwon et al.,
2012; Schnell et al., 2012). Even though NL1 is a postsynaptic
protein, it has been shown tomodulate synaptic vesicle clustering
through direct or indirect interactions with presynaptic proteins.
Indeed, overexpression of NL1 increases the number of vesicles
at the synapse (Dahlhaus et al., 2010), an effect that depends
on the presence of functional scaffolding proteins S-SCAM,
on the postsynaptic side, and N-cadherin, presynaptically
(Stan et al., 2010). In addition, synaptic vesicles can also be
modulated by the association of NL1 with β-neurexin (Dean
et al., 2003). In this regard, we previously reported that the NL1
KO brain shows a significant reduction in several presynaptic
proteins including Nxn-1 and mammalian uncoordinated-
18 (Munc18; Blundell et al., 2010). These alterations alone
could be affecting neurotransmitter release because Munc18
is essential for synaptic vesicle priming (Deák et al., 2009),
whereas neurexins, besides modulating synaptic clustering,
they can also link presynaptic Ca2+ channels to the synaptic
vesicle release machinery (Missler et al., 2003; Kattenstroth et al.,
2004; Zhang et al., 2005). Of related interest are the findings of
Lobo et al describing differential mRNA expression between
direct and indirect pathway MSNs, including a 2-fold difference
in neurexin-1 expression (Lobo et al., 2006). However, NL1
KO mice showed no difference in PPR, even at various Ca2+
concentrations, making the latter possibility of low likelihood.
Importantly, multiple lines of evidence indicate that evoked and
spontaneous neurotransmission may differ in the modulation of
synaptic vesicle release properties (Smith et al., 2012) which may
even utilize different pools of synaptic vesicles (Kavalali, 2015).
This varies among brain regions and synapse types and could
be due to local synapse-specific expression of synaptic proteins
that modulate both types of neurotransmission. Likewise,
differences in the baggage of synaptic proteins that comprise
local release machineries could be involved in the distinct
effects between striatal pathways reported here. If this were
the case, the constitutive absence of NL1 could lead mainly
to postsynaptic alterations in the direct pathway vs. mainly
presynaptic alterations in the indirect pathway. Our present
results leave open this interesting and complex line of inquiry for
future studies.
Similar to several other mouse models of ASD or of OCD
(Greer and Capecchi, 2002; Welch et al., 2007; Etherton et al.,
2009; Shmelkov et al., 2010; Peça et al., 2011), NL1-null mice
show an ∼2-fold increase in repetitive grooming (Blundell et al.,
2010). We do not presently know what the specific impact of
the changes in striatal neurotransmission reported here may
have on grooming behavior of NL1 KO mice, however, some
testable hypotheses may be drawn from the literature. Given that
activation of the direct pathway using DR1 agonists increased
grooming behavior in rodents (Van Wimersma Greidanus
et al., 1989; Berridge and Aldridge, 2000; Taylor et al., 2010),
whereas facilitation of the indirect pathway by pretreatment
with DR2 antagonists prevented the effect of DR1 agonists on
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grooming (Molloy and Waddington, 1987; Taylor et al., 2010),
the emerging model is that dopamine facilitates the activation
of the direct pathway while, at the same time, it dampens the
inhibitory effects of the indirect pathway on motor program
completion. Importantly, antagonism of Glun2A containing-
NMDARs, favors dopaminergic release (Schotanus and Chergui,
2008) and, therefore, could have a stimulating impact on
grooming. This is in agreement with the rescue of grooming
behavior that systemic injections of D-cycloserine have in NL1
KO mice. However, it will remain to be determined in future
studies if reductions in NMDAR currents are intertwined with
the dopaminergic modulation of grooming in this mouse.
In summary, we have demonstrated reduced NMDAR
currents selectively in the direct pathway MSNs of dorsal
striatum in NL1 KO mice. This is due to a selective decrease
of GluN2A-containing NMDAR currents at excitatory
synapses onto direct pathway MSNs. Furthermore, action
potential-independent spontaneous neurotransmission is
selectively reduced in the indirect pathway of NL1 KO mice.
These findings correlate altered striatal synaptic function to
the increased grooming phenotype of NL1 KO mice. Indeed
they lead to testable hypotheses of how altered striatal synaptic
function may result in increased repetitive grooming.
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